9943 related articles for article (PubMed ID: 17427873)
1. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
2. A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.
Chen R; Zhang G; Zhou Y; Li N; Lin J
Diagn Pathol; 2014 Aug; 9():155. PubMed ID: 25116415
[TBL] [Abstract][Full Text] [Related]
3. Predicting cutaneous malignant melanoma patients' survival using deep learning: a retrospective cohort study.
Cai S; Li W; Deng C; Tang Q; Zhou Z
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17103-17113. PubMed ID: 37755576
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-Mediated Microbubble Destruction Inhibits Skin Melanoma Growth by Affecting YAP1 Translation Using Ribosome Imprinting Sequencing.
Wei T; Li L; He Z
Front Oncol; 2021; 11():619167. PubMed ID: 33996543
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanoma in adolescents and young adults.
Buja A; Rugge M; Trevisiol C; Zanovello A; Brazzale AR; Zorzi M; Vecchiato A; Del Fiore P; Tropea S; Chiarion-Sileni V; Rossi CR; Mocellin S
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38709156
[TBL] [Abstract][Full Text] [Related]
6. PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.
Autilio C; Paolillo C; Lavieri MM; Pocino K; De Paolis E; Di Stasio E; Marchetti P; Gian Carlo CA; Capoluongo E
Oncotarget; 2017 Oct; 8(49):85479-85491. PubMed ID: 29156734
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study.
Arias-Mejias SM; Quattrocchi E; Tempel D; Luna-Vargas M; Chen J; Murphree DH; Gjorgova Gjeorgjievski S; Lehman JS; Bridges AG; Dwarkasing J; Meves A
Int J Dermatol; 2020 Nov; 59(11):e431-e433. PubMed ID: 32516450
[No Abstract] [Full Text] [Related]
8. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
9. Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.
Obrist R; Schmidli J; Müller R; Gallati H; Obrecht JP
Cancer Immunol Immunother; 1991; 32(6):406-8. PubMed ID: 2007248
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural organization of nucleoli in benign naevi and malignant melanomas.
Derenzini M; Betts CM; Ceccarelli C; Eusebi V
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(4):343-52. PubMed ID: 2883758
[TBL] [Abstract][Full Text] [Related]
11. A case of superficial spreading melanoma in situ 2.5 mm in diameter.
Ban M; Yoneda K; Yanagihara M; Mori S; Seko T
J Dermatol; 1993 Jul; 20(7):432-5. PubMed ID: 8408926
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of trehalose-loaded liposomes against UVB-induced photodamage in human keratinocytes.
Emanuele E; Bertona M; Sanchis-Gomar F; Pareja-Galeano H; Lucia A
Biomed Rep; 2014 Sep; 2(5):755-759. PubMed ID: 25054023
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of adenosine 3',5'-cyclic monophosphate stimulating agents, vitamin E succinate, and heat on the survival of murine B-16 melanoma cells in culture.
Sahu SN; Prasad KN
Cancer; 1988 Sep; 62(5):949-53. PubMed ID: 2842028
[TBL] [Abstract][Full Text] [Related]
14. Primary oral malignant melanoma: case report.
Bujas T; Pavić I; Prus A; Marusić Z; Balicević D
Acta Clin Croat; 2010 Mar; 49(1):55-9. PubMed ID: 20635585
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional ultrasound imaging. Clinical applications.
Cusumano A; Coleman DJ; Silverman RH; Reinstein DZ; Rondeau MJ; Ursea R; Daly SM; Lloyd HO
Ophthalmology; 1998 Feb; 105(2):300-6. PubMed ID: 9479291
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
Microbiol Immunol; 1996; 40(6):443-9. PubMed ID: 8839430
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma of the hand and foot: diagnosis and management.
Hughes LE; Horgan K; Taylor BA; Laidler P
Br J Surg; 1985 Oct; 72(10):811-5. PubMed ID: 3899242
[TBL] [Abstract][Full Text] [Related]
18. Choroidal neovascularization induced by transcleral microdiathermy for localization of a juxtapapillary choroidal melanoma.
Cohen VM; Hungerford JL
Ophthalmic Surg Lasers Imaging; 2007; 38(5):410-2. PubMed ID: 17955849
[TBL] [Abstract][Full Text] [Related]
19. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
Kirkin AF; Dzhandzhugazyan K; Zeuthen J
Exp Clin Immunogenet; 1998; 15(1):19-32. PubMed ID: 9619397
[TBL] [Abstract][Full Text] [Related]
20. Secretion of both IL-2 and IL-4 by tumor cells results in rejection and immunity.
Strome SE; Chang AE; Shu S; Krauss JC
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):21-32. PubMed ID: 9147701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
